We are grateful to our independent panel of experts who bring specialized knowledge and experience in innovation, healthcare and advocacy to our awards process.
Author, Speaker, Entrepreneur, and Cancer Survivor
In 2008, Randy was diagnosed with Stage III non-small cell lung cancer (NSCLC.) Following diagnosis, the surgeon gave a fairly short life prognosis and was told, ‘Get your things in order and go live your life.’ With this new directive, Randy set about “re-ordering” his life by making a few adjustments and reprioritizing his values. First on the list were his kids; to have them know each other in a meaningful way. Next on the relationship to do’ list, was his extended family with focus primarily on relationships bringing joy and inspiration. Six years following this lifestyle reboot, he continues amongst the living.
With extended warranty in hand, the road led Randy to write it down for posterity sake. The original goal, to provide his kids a reference to some of life’s more cherished moments; according to Randy, “the ones where you learn by making really bad mistakes.” What materialized was, ‘It’s an Extraordinary Life – Don’t Miss It’. The book opened the door to the world of professional speaking and healthcare advocacy. The take away from this experience (of sharing his journey) was to realize how much people engage by listening to stories…real life stories that touch on the fabric of life.
Randy enjoys writing, reading, and of course, telling stories. He feels stories are at the core of everything human. Skiing, golf, and biking round out his activities when he is not shovel deep in the garden. Now closer to his kids, a meaningful relationship with family members, and the greatest network of friends a person could ever desire, fills his life. ”The lion his den, the spider its web, man friendship.” It took cancer to realize the true meaning of this quote. Lastly, one more story to share. In 1988, while sitting on a film set during lunch in Los Angeles, he had the extraordinary experience of receiving a personal one on two concert from Sir George Harrison! Ask him and he’ll tell you the story.
Read more at: ItsAnExtraordinaryLife.com
Managing Director, Business Development
Chris Fidyk is the Managing Director of Business Development at PatientsLikeMe. He joined the company in 2009 and is responsible for structuring collaborations with drug developers, health insurers, academic institutions, and government agencies that align the needs of patients and industry.
Before joining PatientsLikeMe, Chris began his healthcare career at Amgen in the late 1990s. Over the years, he held a number of positions in sales and marketing before leaving Amgen for PatientsLikeMe. Originally trained as a computer scientist, Chris shifted his focus to business in the early 2000s. He earned his BS in computer science from Columbia University and his MBA in entrepreneurship from UCLA.
A native of Southern California, Chris and his wife Erin currently reside in Columbus, Ohio with their dog Seamus.
Read more at: www.patientslikeme.com
Paul Howard, PhD
Director, Center for Medical Progress
Manhattan Institute for Policy Research
(Returning judge from 2013!)
Paul Howard, Ph.D, is a Manhattan Institute senior fellow and director of the Manhattan Institute’s Center for Medical Progress. Dr. Howard is the managing editor of Medical Progress Today, a blog providing a forum for economists, scientists, and policy experts to explore the scientific, regulatory, and market frameworks that will best support twenty-first century medical innovation. Dr. Howard has written on a wide variety of medical policy issues, including FDA reform, biopharmaceutical innovation, consumer-driven health care, Medicare and Medicaid policy, and health care reform. His columns and essays have appeared in national publications, including Bloomberg View, The Wall Street Journal, National Affairs, USA Today, Real Clear Politics, New York Post, Investor’s Business Daily, Health Affairs, and FoxNews.com.
Dr. Howard is also a member of the Manhattan Institute’s Project FDA, a committee of physician-scientists, economists, medical ethicists, and policy experts. Their purpose is to show how twenty-first-century technologies can help better inform FDA regulations and accelerate the drug-development and drug-approval process while maintaining drug safety. In 2012, he served on the Health Care Policy Advisory Group for the presidential campaign of former Massachusetts governor Mitt Romney. He has also testified twice before Congress. Dr. Howard joined the Manhattan Institute in 2000, working as deputy director of the Center for Legal Policy where he edited research papers, managed legal policy analyses, and organized conferences. He received his Ph.D. in political science from Fordham University in 2003, and is a graduate of the College of the Holy Cross in Worcester, Massachusetts.
Read more at: www.manhattan-institute.org
Ilisa Halpern Paul, MPP
District Policy Group at Drinker Biddle & Reath
Ilisa Halpern Paul is the President of the District Policy Group at Drinker Biddle & Reath and has more than 20 years of experience in government relations, advocacy, and public policy. Ilisa advises patient advocacy organizations, health professional societies, health and hospital systems, medical technology companies, and other entities in the health care industry with respect to advancing their legislative, regulatory, advocacy, grassroots, and programmatic policy agendas.
In her consultant role, from 2001 through 2013 Ms. Paul served as Health Policy Associate to the Oncology Nursing Society and since 2005, she has provided federal government relations representation and counsel to the Ovarian Cancer National Alliance. Prior to her 13 years as a health policy and advocacy consultant, Ms. Paul served as Federal Government Relations Director for the American Cancer Society in its National Government Relations Department in Washington, DC and worked as Director of Federal Affairs for the American Public Health Association, also headquartered in the nation’s capital. Ms. Paul is a nationally-recognized expert in patient advocacy and oncology health policy.
Ms. Paul earned a bachelor’s degree in English at UCLA and a master’s of public policy degree from Georgetown University’s Public Policy Institute. She started her public policy career in Washington, DC working on the legislative staff of U.S. Senator Dianne Feinstein. From 2004-2011, she served on the editorial advisory board of Hematology Oncology News & Issues.
Read more at: www.districtpolicygroup.com
Business Development and Global Alliances
Angus Grant joined Celgene as Vice President North American Regulatory Affairs in September 2006, first to manage and grow the regulatory staff and function in the Summit NJ Headquarters, and then in Europe. After 3 years as Head of Europe RA, Angus has returned to the Summit NJ Headquarters as VP, Business Development and Global Alliances, where he has since closed multiple innovative deals and collaborations and built the Alliance Management function, now managing over 30 collaborations ranging from pharma, biotech, academic and patient advocacy.
Prior to joining Celgene, Dr. Grant was the Executive Director for Alliance Management for Novartis Oncology, Senior Director, Regulatory Affairs, Oncology Strategy with Merck KGaA/EMD Pharmaceuticals, and previously help positions in Regulatory Affairs at both Aventis Pharmaceuticals and SmithKline Beecham Pharmaceuticals. Prior to working in industry, Dr. Grant served as a Senior Staff Fellow at the U.S. Food and Drug Administration Center for Biologics, Office of Therapeutics, and conducted his post-doctoral research in immunotherapy with the National Cancer Institute. Dr. Grant received his Ph.D. in Anatomy/Immunology from the Medical College of Virginia.
Read more at: www.celgene.com